Dr. Todd Druley
Chief Medical Officer

Aaron Llanso
Senior Director, Clinical Applications

The Tapestri Single-cell Multi-omics MRD (scMRD) Assay for AML provides institutions early access to our scMRD technology, which allows for MRD detection with unparalleled resolution, sensitivity and specificity.

You're invited to join us for the Tapestri scMRD for AML Summit - a special in-person event to learn more about Mission Bio's single-cell MRD technology. Space is limited - register by Friday, August 5 to reserve your spot!

INFORMATION & SCHEDULE

DATE: Tuesday, August 16
START TIME: 11:30a

Event to include lunch, happy hour, and dinner for all guests

LOCATION: New York Hilton Midtown, 1335 Avenue of the Americas New York, NY 10019

Some agenda highlights include:

  • – Keynote presentation from Dr. Ross Levine including an overview of the first scMRD data
  • – "Opportunities for single-cell multi-omics in the clinic: MRD and beyond" - a panel discussion with Dr. Ross Levine, Dr. Marina Konopleva, Dr. Saar Gill, Dr. Wenbin Xiao, and Dr. Mikhail Roshal and moderated by Dr. Todd Druley
  • – Industry perspective on MRD challenges, needs, and opportunities with Dr. Christina Guttke
  • – An insider look into our Early Access Program and how to sign up
  • – A sneak peek into our bioinformatics pipeline and upcoming software updates
  • – And much more!

We'll be adding even more to our agenda, so stay tuned!